With a continually growing patient population and no approved treatments, NASH presents a huge unmet clinical need. Drug developers are racing to bring an effective therapeutic to market as
quickly as possible. However, developing a robust market entry strategy for Europe is not without its challenges. Join your peers and industry leading experts at this workshop to learn how to navigate the European drug development landscape.
Attend this expert led workshop to:
Workshop Leader: George O’Rourke, Managing Director, GO Biotech Consulting